Curevac N.V. sell Amped
Start price
21.06.21
/
0%
€49.88
Target price
17.06.22
-
Performance (%)
2.00%
End price
22.06.21
€50.88
Summary
This prediction ended on 22.06.21 with a price of €50.88. With a performance of 2.00%, the SELL prediction by Amped for Curevac N.V. was trending in the wrong direction This prediction was marked as speculative and is excluded from Amped's performance statistics.Performance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Curevac N.V. | 5.450% | 5.450% | - | - |
iShares Core DAX® | 2.821% | -1.953% | 15.071% | 11.862% |
iShares Nasdaq 100 | 5.285% | -5.092% | 29.254% | 40.075% |
iShares Nikkei 225® | 3.687% | -4.221% | 14.286% | 6.629% |
iShares S&P 500 | 3.577% | -2.240% | 25.546% | 38.398% |
According to Amped what are the pros and cons of Curevac N.V. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Fair valuation
EBIT growth >5% per year expected
Revenue growth >5% per year expected
Good culture
Differentiated customer and product portfolio
Well known brand
Small cyclical dependencies
Top 10 in its market
Capable Management
Very Future proof/growth oriented business model
Cons
Few uniques
Comments by Amped for this prediction
In the thread Curevac N.V. diskutieren
Sell Curevac N.V.
In the thread Trading Curevac N.v.
Sell beendet
Stopped prediction by Amped for Curevac N.V.
Curevac N.V.
Start price
Target price
Perf. (%)
€50.88
22.06.21
22.06.21
-
17.06.22
17.06.22
-72.98%
18.06.22
18.06.22
Could be worthwhile Investment >10% per year
Fair valuation
EBIT growth >5% per year expected
Revenue growth >5% per year expected
Curevac N.V.
Start price
Target price
Perf. (%)
€48.56
17.06.21
17.06.21
-
17.06.22
17.06.22
2.73%
21.06.21
21.06.21
Could be worthwhile Investment >10% per year
Fair valuation
EBIT growth >5% per year expected
Revenue growth >5% per year expected